| Dr Pamela Sue Wiley, PHD, CCC-SLP | |
|
5761 Buckingham Pkwy, Culver City, CA 90230-6515 | |
| (310) 649-6199 | |
| (310) 649-5597 |
| Full Name | Dr Pamela Sue Wiley |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5761 Buckingham Pkwy, Culver City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356664643 | NPI | - | NPPES |
| GSP000290 | Other | CA | MEDI-CAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SP3380 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Sue Wiley, PHD, CCC-SLP 5761 Buckingham Pkwy, Culver City, CA 90230-6515 Ph: (310) 649-6199 | Dr Pamela Sue Wiley, PHD, CCC-SLP 5761 Buckingham Pkwy, Culver City, CA 90230-6515 Ph: (310) 649-6199 |
News Archive
Rochelle Schwartz-Bloom, a Duke University pharmacology professor who left the lab bench to focus on science education, has developed a tactic for keeping students hands in the air at the end of class.
Endo Pharmaceuticals announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510.
Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.
New research suggests that synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults. Although those diseases, beta-thalassemia and polycythemia vera, have opposite effects on red blood cell production, treating animals with minihepcidin helps to restore normal levels of red blood cells and reduces spleen enlargement. It also controls the accumulation of excess levels of iron in beta-thalassemia that often causes severe toxic effects.
› Verified 9 days ago
Belinda Williams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5761 Buckingham Pkwy, Culver City, CA 90230 Phone: 310-649-6199 | |
Miss Angela Jean Adley, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11825 Major St, Culver City, CA 90230 Phone: 310-915-6100 | |
Diane Bernstein, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5761 Buckingham Pkwy, Culver City, CA 90230 Phone: 310-649-6199 | |
Regina Del Carmen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5761 Buckingham Pkwy, Culver City, CA 90230 Phone: 310-649-6199 | |
Jennifer Nelly Razo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6820 S Centinela Ave, Culver City, CA 90230 Phone: 310-337-7115 | |
Haley Marie St. Martin, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5901 Green Valley Cir Ste 130, Culver City, CA 90230 Phone: 858-254-4840 | |
Cheyanne Pi Ling Chen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6059 Bristol Pkwy, #100, Culver City, CA 90230 Phone: 866-278-1520 |